© 2026 Connecticut Public

FCC Public Inspection Files:
WEDH · WEDN · WEDW · WEDY
WEDW-FM · WNPR · WPKT · WRLI-FM
Public Files Contact · ATSC 3.0 FAQ
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations

How Yale's 3D Printing Venture Could Solve the Organ Donor Problem

Organovo
/
Yale University
A 3D bioprinted blood vessel.
It may sound like a bit of science fiction, but 3D bioprinting has been around for seven years.

Worldwide, the number and quality of vital organ donors has decreased. Yale University has announced a new venture with a 3D biology company to develop 3D-printed tissue and organs.

So, how do you build a new liver or kidney using a 3D printer?

Dr. John Geibel, vice chair and director of surgical research at Yale School of Medicine, said to think of your old inkjet printer. "In this case, the cartridges are filled with either cellular material, or some of these gel-like, matrigel, hydragel materials that is going to be the jelly-like foundation that holds the cells in place while the organ is being printed."

Geibel said the gel acts as scaffolding, or the frame of a house, a place where the cells grow into a new organ.

It may sound like a bit of science fiction, but 3D bioprinting has been around for seven years. While transplant-ready, 3D-printed organs may be years off, the technology has already yielded various transplantable tissue and vascular grafts.

Geibel said that when the technology is up and running, 3D-printed organ transplants will be better than donor transplants. "Not only that it's going to provide organs," he said, "it's going to provide organs that are coming from cellular material from the individual. Then many of these immunotoxicity drugs that have to go along with the transplant -- which can have serious side effects -- will fall by the wayside."

Yale School of Medicine's Department of Surgery and the School of Engineering and Applied Science will work together with Organovo, a 3D biology company that already has printed a small, fully-functional liver for the purpose of pharmaceutical testing.

Ray Hardman was an arts and culture reporter at Connecticut Public.

Federal funding is gone.

Congress has eliminated all funding for public media.

That means $2.1 million per year that Connecticut Public relied on to deliver you news, information, and entertainment programs you enjoyed is gone.

The future of public media is in your hands.

All donations are appreciated, but we ask in this moment you consider starting a monthly gift as a Sustainer to help replace what’s been lost.

SOMOS CONNECTICUT is an initiative from Connecticut Public, the state’s local NPR and PBS station, to elevate Latino stories and expand programming that uplifts and informs our Latino communities. Visit CTPublic.org/latino for more stories and resources. For updates, sign up for the SOMOS CONNECTICUT newsletter at ctpublic.org/newsletters.

SOMOS CONNECTICUT es una iniciativa de Connecticut Public, la emisora local de NPR y PBS del estado, que busca elevar nuestras historias latinas y expandir programación que alza y informa nuestras comunidades latinas locales. Visita CTPublic.org/latino para más reportajes y recursos. Para noticias, suscríbase a nuestro boletín informativo en ctpublic.org/newsletters.

Federal funding is gone.

Congress has eliminated all funding for public media.

That means $2.1 million per year that Connecticut Public relied on to deliver you news, information, and entertainment programs you enjoyed is gone.

The future of public media is in your hands.

All donations are appreciated, but we ask in this moment you consider starting a monthly gift as a Sustainer to help replace what’s been lost.

Related Content